Cargando…

Gene expression and immune infiltration in melanoma patients with different mutation burden

BACKGROUND: Immunotherapy is a vital component in cancer treatment. However, due to the complex genetic bases of cancer, a clear prediction index for efficacy has not been established. Tumor mutation burden (TMB) is one of the essential factors that affect immunotherapeutic efficacies, but it has no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liwei, Chen, Fu, Liu, Rui, Shi, Lei, Zhao, Guosheng, Yan, Zhengjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034108/ https://www.ncbi.nlm.nih.gov/pubmed/33836680 http://dx.doi.org/10.1186/s12885-021-08083-1

Ejemplares similares

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
por: Yan, Junya, et al.
Publicado: (2020)

Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma
por: Zhao, Yulan, et al.
Publicado: (2022)

Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer
por: Wu, Zonglong, et al.
Publicado: (2020)

Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer
por: Jiang, Ai-Min, et al.
Publicado: (2021)

The influence of tumour mutational burden on renal cancer immune infiltration and survival
por: Byrne, Matthew H. V., et al.
Publicado: (2020)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu, Nan, et al.
Publicado: (2021)

Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma
por: Qin, Rujia, et al.
Publicado: (2021)

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
por: Fu, Jing, et al.
Publicado: (2021)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma
por: Liu, Shougang, et al.
Publicado: (2021)

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data
por: Liu, Shaoqing, et al.
Publicado: (2021)

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023)

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
por: Bi, Fangfang, et al.
Publicado: (2020)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma
por: Zeng, Yangyang, et al.
Publicado: (2021)

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma
por: Lv, Haozhen, et al.
Publicado: (2022)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

A comprehensive analysis of IDO1 expression with tumour‐infiltrating immune cells and mutation burden in gynaecologic and breast cancers
por: Feng, Xu, et al.
Publicado: (2020)

The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
por: Yuan, Cheng, et al.
Publicado: (2020)

Comprehensive Analysis of the Relationships Between Tumor Mutation Burden With Immune Infiltrates in Cervical Cell Carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
por: Wen, Fang, et al.
Publicado: (2021)

Hypoxia Confers Tumor with a Higher Immune Infiltration but Lower Mutation Burden in Gastrointestinal Cancer
por: Hu, Junjie, et al.
Publicado: (2022)

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
por: Jiang, Tao, et al.
Publicado: (2019)

Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma
por: Li, Ai-lan, et al.
Publicado: (2021)

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023)

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations
por: Ma, Tiantian, et al.
Publicado: (2022)

Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma
por: Zhang, Chuan, et al.
Publicado: (2021)

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2021)

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
por: Liu, Zijian, et al.
Publicado: (2020)

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
por: Cui, Shengjin, et al.
Publicado: (2023)

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes
por: Andrieu, Charlotte, et al.
Publicado: (2022)

TNFSF10, an autophagy related gene, was a prognostic and immune infiltration marker in skin cutaneous melanoma
por: Xue, Lei, et al.
Publicado: (2023)

Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma
por: Zhao, Han, et al.
Publicado: (2021)

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2021)

Comprehensive Analysis of the Tumor Microenvironment in Cutaneous Melanoma associated with Immune Infiltration
por: Wang, Pan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_16la19kmpk483kqbbq7f6irmsf